Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1697 (1-2) , 17-27
- https://doi.org/10.1016/j.bbapap.2003.11.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I StudiesJournal of Clinical Oncology, 2003
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Seminars in Oncology, 2003
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- CGP 79787D (PTK787/ZK222584), CGP 84738, NVP-AAC789, NVP-AAD777 and related 1-anilino-(4-pyridylmethyl)phthalazines as inhibitors of VEGF- and bFGF-induced angiogenesisDrugs of the Future, 2002
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityJournal of Clinical Investigation, 2000
- Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene familyBiochemical and Biophysical Research Communications, 1989
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971